questionsmedicales.fr
Composés polycycliques
Hydrocarbures aromatiques polycycliques
Phénanthrènes
Morphinanes
Dérivés de la morphine
Dérivés de la morphine : Questions médicales fréquentes
Termes MeSH sélectionnés :
Substance Abuse Detection
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Dérivés de la morphine : Questions médicales les plus fréquentes",
"headline": "Dérivés de la morphine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Dérivés de la morphine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-15",
"dateModified": "2025-04-10",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Dérivés de la morphine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Morphinanes",
"url": "https://questionsmedicales.fr/mesh/D009019",
"about": {
"@type": "MedicalCondition",
"name": "Morphinanes",
"code": {
"@type": "MedicalCode",
"code": "D009019",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Codéine",
"alternateName": "Codeine",
"url": "https://questionsmedicales.fr/mesh/D003061",
"about": {
"@type": "MedicalCondition",
"name": "Codéine",
"code": {
"@type": "MedicalCode",
"code": "D003061",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.576.149"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hydrocodone",
"alternateName": "Hydrocodone",
"url": "https://questionsmedicales.fr/mesh/D006853",
"about": {
"@type": "MedicalCondition",
"name": "Hydrocodone",
"code": {
"@type": "MedicalCode",
"code": "D006853",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.576.149.287"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Oxycodone",
"alternateName": "Oxycodone",
"url": "https://questionsmedicales.fr/mesh/D010098",
"about": {
"@type": "MedicalCondition",
"name": "Oxycodone",
"code": {
"@type": "MedicalCode",
"code": "D010098",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.576.149.575"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Dihydromorphine",
"alternateName": "Dihydromorphine",
"url": "https://questionsmedicales.fr/mesh/D004090",
"about": {
"@type": "MedicalCondition",
"name": "Dihydromorphine",
"code": {
"@type": "MedicalCode",
"code": "D004090",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.576.350"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Éthylmorphine",
"alternateName": "Ethylmorphine",
"url": "https://questionsmedicales.fr/mesh/D005036",
"about": {
"@type": "MedicalCondition",
"name": "Éthylmorphine",
"code": {
"@type": "MedicalCode",
"code": "D005036",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.576.430"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Héroïne",
"alternateName": "Heroin",
"url": "https://questionsmedicales.fr/mesh/D003932",
"about": {
"@type": "MedicalCondition",
"name": "Héroïne",
"code": {
"@type": "MedicalCode",
"code": "D003932",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.576.445"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hydromorphone",
"alternateName": "Hydromorphone",
"url": "https://questionsmedicales.fr/mesh/D004091",
"about": {
"@type": "MedicalCondition",
"name": "Hydromorphone",
"code": {
"@type": "MedicalCode",
"code": "D004091",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.576.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Morphine",
"alternateName": "Morphine",
"url": "https://questionsmedicales.fr/mesh/D009020",
"about": {
"@type": "MedicalCondition",
"name": "Morphine",
"code": {
"@type": "MedicalCode",
"code": "D009020",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.576.571"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Oxymorphone",
"alternateName": "Oxymorphone",
"url": "https://questionsmedicales.fr/mesh/D010111",
"about": {
"@type": "MedicalCondition",
"name": "Oxymorphone",
"code": {
"@type": "MedicalCode",
"code": "D010111",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.576.692"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thébaïne",
"alternateName": "Thebaine",
"url": "https://questionsmedicales.fr/mesh/D013797",
"about": {
"@type": "MedicalCondition",
"name": "Thébaïne",
"code": {
"@type": "MedicalCode",
"code": "D013797",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D04.615.723.795.576.856"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Dérivés de la morphine",
"alternateName": "Morphine Derivatives",
"code": {
"@type": "MedicalCode",
"code": "D009022",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Richard Ian Samuels",
"url": "https://questionsmedicales.fr/author/Richard%20Ian%20Samuels",
"affiliation": {
"@type": "Organization",
"name": "Department of Entomology and Plant Pathology, State University of North Fluminense Darcy Ribeiro, Campos dos Goytacazes, RJ, Brazil."
}
},
{
"@type": "Person",
"name": "Robert J Carey",
"url": "https://questionsmedicales.fr/author/Robert%20J%20Carey",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychiatry SUNY Upstate Medical University, 800 Irving Avenue, Syracuse, NY 13210, USA."
}
},
{
"@type": "Person",
"name": "Marinete Pinheiro Carrera",
"url": "https://questionsmedicales.fr/author/Marinete%20Pinheiro%20Carrera",
"affiliation": {
"@type": "Organization",
"name": "Behavioral Pharmacology Group, Laboratory of Animal Morphology and Pathology, State University of North Fluminense Darcy Ribeiro, Avenida Alberto Lamego, 2000, Campos dos Goytacazes 28013-602, RJ, Brazil. Electronic address: marinete@uenf.br."
}
},
{
"@type": "Person",
"name": "Hossein Azizi",
"url": "https://questionsmedicales.fr/author/Hossein%20Azizi",
"affiliation": {
"@type": "Organization",
"name": "Department of Physiology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. Electronic address: azizih@modares.ac.ir."
}
},
{
"@type": "Person",
"name": "Mohammad-Reza Zarrindast",
"url": "https://questionsmedicales.fr/author/Mohammad-Reza%20Zarrindast",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacology School of Medicine, Tehran University of Medical Sciences, Tehran, Iran."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Concentrations of LSD, 2-oxo-3-hydroxy-LSD, and iso-LSD in hair segments of 18 drug abusers.",
"datePublished": "2023-02-02",
"url": "https://questionsmedicales.fr/article/36753839",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.forsciint.2023.111578"
}
},
{
"@type": "ScholarlyArticle",
"name": "Wastewater analysis for new psychoactive substances and cocaine and cannabis in a Northern Ireland Prison.",
"datePublished": "2023-10-30",
"url": "https://questionsmedicales.fr/article/37903846",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-44453-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Target and suspect screening of (new) psychoactive substances in South Korean wastewater by LC-HRMS.",
"datePublished": "2023-03-04",
"url": "https://questionsmedicales.fr/article/36871726",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.scitotenv.2023.162613"
}
},
{
"@type": "ScholarlyArticle",
"name": "Amphetamine or skin cream? The impact of the sampling site on the concentration of controlled substances: a case report.",
"datePublished": "2022-05-24",
"url": "https://questionsmedicales.fr/article/35606594",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00414-022-02838-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Facile fabrication of the immuno-MALDI-MS chip for the enrichment of abused drug in human urine integrated with MALDI-MS analysis.",
"datePublished": "2024-09-11",
"url": "https://questionsmedicales.fr/article/39396289",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.aca.2024.343224"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés polycycliques",
"item": "https://questionsmedicales.fr/mesh/D011083"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hydrocarbures aromatiques polycycliques",
"item": "https://questionsmedicales.fr/mesh/D011084"
},
{
"@type": "ListItem",
"position": 4,
"name": "Phénanthrènes",
"item": "https://questionsmedicales.fr/mesh/D010616"
},
{
"@type": "ListItem",
"position": 5,
"name": "Morphinanes",
"item": "https://questionsmedicales.fr/mesh/D009019"
},
{
"@type": "ListItem",
"position": 6,
"name": "Dérivés de la morphine",
"item": "https://questionsmedicales.fr/mesh/D009022"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Dérivés de la morphine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Dérivés de la morphine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Dérivés de la morphine",
"description": "Comment diagnostiquer une dépendance aux dérivés de la morphine ?\nQuels tests sont utilisés pour évaluer l'usage de morphine ?\nQuels signes cliniques indiquent une surdose de morphine ?\nComment évaluer l'efficacité d'un traitement à base de morphine ?\nQuels critères sont utilisés pour le sevrage des dérivés de morphine ?",
"url": "https://questionsmedicales.fr/mesh/D009022?mesh_terms=Substance+Abuse+Detection&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Dérivés de la morphine",
"description": "Quels sont les symptômes d'une surdose de morphine ?\nQuels effets secondaires courants des dérivés de morphine ?\nComment reconnaître une réaction allergique aux dérivés de morphine ?\nQuels symptômes indiquent une dépendance aux opioïdes ?\nQuels signes d'intoxication aux dérivés de morphine ?",
"url": "https://questionsmedicales.fr/mesh/D009022?mesh_terms=Substance+Abuse+Detection&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Dérivés de la morphine",
"description": "Comment prévenir la dépendance aux dérivés de morphine ?\nQuelles mesures de sécurité pour l'utilisation de morphine ?\nComment sensibiliser aux risques des dérivés de morphine ?\nQuels conseils pour éviter les surdoses de morphine ?\nComment éduquer les patients sur les opioïdes ?",
"url": "https://questionsmedicales.fr/mesh/D009022?mesh_terms=Substance+Abuse+Detection&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Dérivés de la morphine",
"description": "Quels traitements existent pour la dépendance aux dérivés de morphine ?\nComment traiter une surdose de morphine ?\nQuels médicaments sont utilisés pour le sevrage des opioïdes ?\nComment gérer les effets secondaires des dérivés de morphine ?\nQuels sont les traitements non médicamenteux pour la douleur ?",
"url": "https://questionsmedicales.fr/mesh/D009022?mesh_terms=Substance+Abuse+Detection&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Dérivés de la morphine",
"description": "Quelles complications peuvent survenir avec l'utilisation de morphine ?\nComment la morphine affecte-t-elle le système immunitaire ?\nQuels risques de surdose avec les dérivés de morphine ?\nQuelles sont les conséquences d'une surdose de morphine ?\nComment la morphine peut-elle affecter la santé mentale ?",
"url": "https://questionsmedicales.fr/mesh/D009022?mesh_terms=Substance+Abuse+Detection&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Dérivés de la morphine",
"description": "Quels sont les facteurs de risque de dépendance aux dérivés de morphine ?\nComment l'âge influence-t-il l'utilisation de morphine ?\nQuels rôles jouent les antécédents médicaux dans l'usage de morphine ?\nComment le sexe influence-t-il la réponse à la morphine ?\nQuels facteurs environnementaux augmentent le risque d'abus de morphine ?",
"url": "https://questionsmedicales.fr/mesh/D009022?mesh_terms=Substance+Abuse+Detection&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dépendance aux dérivés de la morphine ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'évaluation des symptômes de dépendance et des antécédents médicaux."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'usage de morphine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests urinaires et sanguins peuvent détecter la présence de morphine et ses dérivés."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une surdose de morphine ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent la dépression respiratoire, la somnolence excessive et la confusion."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité d'un traitement à base de morphine ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par la réduction de la douleur et l'amélioration de la qualité de vie."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le sevrage des dérivés de morphine ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent la durée d'utilisation, la dose et les symptômes de sevrage observés."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une surdose de morphine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent la respiration lente, la confusion et la perte de conscience."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires courants des dérivés de morphine ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent constipation, nausées, somnolence et vertiges."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction allergique aux dérivés de morphine ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les réactions allergiques peuvent se manifester par des éruptions cutanées, démangeaisons ou œdème."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une dépendance aux opioïdes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des envies intenses, des comportements de recherche de drogue et des symptômes de sevrage."
}
},
{
"@type": "Question",
"name": "Quels signes d'intoxication aux dérivés de morphine ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent confusion, somnolence, pupilles constrictes et respiration ralentie."
}
},
{
"@type": "Question",
"name": "Comment prévenir la dépendance aux dérivés de morphine ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par une prescription prudente, l'éducation des patients et le suivi régulier."
}
},
{
"@type": "Question",
"name": "Quelles mesures de sécurité pour l'utilisation de morphine ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les mesures incluent le stockage sécurisé, l'éducation sur les risques et le suivi médical."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser aux risques des dérivés de morphine ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des campagnes d'information et des formations pour les professionnels de santé sont essentielles."
}
},
{
"@type": "Question",
"name": "Quels conseils pour éviter les surdoses de morphine ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez l'automédication, respectez les doses prescrites et consultez un médecin en cas de doute."
}
},
{
"@type": "Question",
"name": "Comment éduquer les patients sur les opioïdes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fournissez des informations sur les risques, les effets secondaires et les alternatives thérapeutiques."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour la dépendance aux dérivés de morphine ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thérapie comportementale, les médicaments et le soutien psychologique."
}
},
{
"@type": "Question",
"name": "Comment traiter une surdose de morphine ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement comprend l'administration de naloxone et des soins d'urgence pour stabiliser le patient."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour le sevrage des opioïdes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme la méthadone et la buprénorphine sont utilisés pour le sevrage."
}
},
{
"@type": "Question",
"name": "Comment gérer les effets secondaires des dérivés de morphine ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut l'ajustement de la dose, l'utilisation de laxatifs et le suivi médical régulier."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements non médicamenteux pour la douleur ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la physiothérapie, l'acupuncture et les techniques de relaxation."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'utilisation de morphine ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la dépression respiratoire, la constipation sévère et la dépendance."
}
},
{
"@type": "Question",
"name": "Comment la morphine affecte-t-elle le système immunitaire ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation prolongée de morphine peut entraîner une immunosuppression et augmenter le risque d'infections."
}
},
{
"@type": "Question",
"name": "Quels risques de surdose avec les dérivés de morphine ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le risque de surdose augmente avec l'usage combiné d'autres dépresseurs du système nerveux central."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une surdose de morphine ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les conséquences peuvent inclure des lésions cérébrales, des troubles respiratoires et la mort."
}
},
{
"@type": "Question",
"name": "Comment la morphine peut-elle affecter la santé mentale ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation de morphine peut entraîner des troubles de l'humeur, de l'anxiété et des troubles cognitifs."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de dépendance aux dérivés de morphine ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents de dépendance, des troubles mentaux et l'usage prolongé."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il l'utilisation de morphine ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées sont plus susceptibles de développer des effets secondaires et une dépendance."
}
},
{
"@type": "Question",
"name": "Quels rôles jouent les antécédents médicaux dans l'usage de morphine ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents de troubles de l'humeur ou de dépendance augmentent le risque d'abus."
}
},
{
"@type": "Question",
"name": "Comment le sexe influence-t-il la réponse à la morphine ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études montrent que les femmes peuvent être plus sensibles aux effets analgésiques et secondaires."
}
},
{
"@type": "Question",
"name": "Quels facteurs environnementaux augmentent le risque d'abus de morphine ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un environnement de stress, de pression sociale ou d'accès facile aux opioïdes augmente le risque."
}
}
]
}
]
}
Lysergic acid diethylamide (LSD) is one of the most widely abused hallucinogens, which can alter consciousness, produce mental disorder, and cause harmful behavior. 1-Propionyl-LSD (1 P-LSD), a novel ...
The global drug market has been significantly impacted by the emergence of new psychoactive substances, leading to challenges in creating effective legislative controls and their use within recreation...
New psychoactive substances (NPS) are a type of abused drug designed to mimic the effects of the currently known illicit drugs, whose structures are constantly changing to escape surveillance. The qui...
This case report demonstrates the impact of different sampling sites on the quantification of narcotic substances. In 2020, officers secured a syringe containing a light-yellow paste-like substance, f...
Drug abuse can result in both physical and mental health issues for individuals, and can also contribute to broader societal problems. The number of drug abuse cases rose to 296 million in 2021. The s...
The immuno-MALDI-MS chip was successfully prepared by coating an aluminum chip with antibody-conjugated boronic acid-modified gold nanoparticles. Ketamine, a frequently abused illicit drug, served as ...
A straightforward, cost-effective and sensitive method for the selective enrichment and absolute quantification of abused drugs was developed using a homemade immuno-MALDI-MS chip integrated with MALD...
Wastewater (WW)-based epidemiology is an approach for the objective surveillance of the consumption of (illicit) drugs in populations. The aims of this study were to monitor drugs of abuse, cognitive ...
Hair testing is a useful tool to investigate suspected pediatric exposure to drugs of abuse. Newborns and young children are at high risk of exposure to drugs of abuse from parents or caregivers who c...
Perinatal substance abuse (PSA) is associated with increased risk of prematurity, low birth weight, neonatal abstinence syndrome, behavioral issues and learning difficulties. It is imperative that rob...
This is a cross-sectional study using questionnaires to survey healthcare professionals (HCPs) working in a tertiary maternity unit (...
The majority of HCPs were not confident in the antenatal management (75.6%,...
Our study highlights the urgent need for increased training on PSA to enhance care and reduce stigma. It is imperative that staff training, drug liaison midwives and dedicated clinics are introduced t...
The presence of pharmaceuticals (PHA) and narcotics (NAR) in wastewater (WW) has attracting growing interest due to concern for aquatic environment and the possibility to exploit their presence to est...
Substance abuse remains a challenging public health issue, especially among young people. It has been shown that poor sleep and substance abuse may have mutual intensifying effects. This study aimed t...
The participants were the students of the Faculty of Sciences, University of Guilan, Iran in 2021. Data were collected through a researcher-made demographic questionnaire, the first two questions of t...
A total of 222 students entered the study from March to August 2021. The rates of substance abuse in the past three months and lifetime were 35.6% and 45.5%, respectively. The most common type of subs...
This study showed that substance abuse was significantly associated with sleep disturbances. The study results also illustrated an upward trend of substance abuse in recent years among students in Ras...